Brief report: No excess risks in offspring with paternal preconception exposure to disease-modifying antirheumatic drugs

Arthritis and Rheumatology

Volumn 67, Issue 1, 2015, Pages 296-301

  Wallenius, Marianne ^a   Lie, Elisabeth ^b   Daltveit, Anne K ^c   Salvesen, Kjell Å ^d,h   Skomsvoll, Johan F ^a   Kalstad, Synøve ^e   Lexberg, Åse S ^f   Mikkelsen, Knut ^g   Kvien, Tore K ^b   Østensen, Monika ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b DIAKONHJEMMET HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^f VESTRE VIKEN HOSPITAL TRUST   (Norway)

^g Hospital for Rheumatic Diseases   (Norway)

^h NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT;

ADULT; ARTHRITIS; ARTICLE; BIRTH; CONCEPTION; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; FEMALE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEWBORN; OBSERVATIONAL STUDY; PES EQUINOVARUS; PREGNANCY OUTCOME; PROGENY; RISK ASSESSMENT; ADOLESCENT; ADVERSE EFFECTS; CHEMICALLY INDUCED; COMPARATIVE STUDY; MIDDLE AGED; NORWAY; PRECONCEPTION INJURIES; PREGNANCY; REGISTER; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RHEUMATIC DISEASES; RISK FACTOR; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NORWAY; PATERNAL EXPOSURE; PRECONCEPTION INJURIES; PREGNANCY; PREGNANCY OUTCOME; REGISTRIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84919934909     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38919     Document Type: Article

References (14)

1. Wallenius M, Skomsvoll JF, Irgens LM, Salvesen KA, Nordvag BY, Koldingsnes W, et al. Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth. Arthritis Rheum 2011; 63: 1534-42.
2. De Man YA, Hazes JM, van der Heide H, Willemsen SP, de Groot CJ, Steegers EA, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 2009; 60: 3196-206.
3. Ostensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006; 8: 209.
4. Irgens LM,. The Medical Birth Registry of Norway: epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000; 79: 435-9.
5. Kvien TK, Heiberg, Lie E, Kaufmann C, Mikkelsen K, Nordvag BY, et al. A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. Clin Exp Rheumatol 2005; 23: S188-94.
6. European Surveillance of Congenital Anomalies, EUROCAT. Guide 1.4, chapter 3.3: coding of EUROCAT subgroups of congenital anomalies. URL: http://www.eurocat-network.eu/content/EUROCAT-Guide-1.4-Chapter-3.3.pdf.
7. Terada M, Matsuda Y, Ogawa M, Matsui H, Satoh S,. Effects of maternal factors on birth weight in Japan. J Pregnancy 2013; 2013: 172395.
8. Weber-Schoendorfer C, Hoeltzenbein M, Wacker E, Meister R, Schaefer C,. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study. Rheumatology (Oxford) 2014; 53: 757-63.
9. Teruel C, Lopez-San Roman A, Bermejo F, Taxonera C, Perez-Calle JL, Gisbert JP, et al. Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines. Am J Gastroenterol 2010; 105: 2003-8.
10. Moody GA, Probert C, Jayanthi V, Mayberry JF,. The effects of chronic ill health and treatment with sulphasalazine on fertility amongst men and women with inflammatory bowel disease in Leicestershire. Int J Colorectal Dis 1997; 12: 220-4.
11. Viktil KK, Engeland A, Furu K,. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol 2012; 41: 196-201.
12. Myklestad K, Vatten LJ, Salvesen KA, Davey Smith G, Romundstad PR,. Hypertensive disorders in pregnancy and paternal cardiovascular risk: a population-based study. Ann Epidemiol 2011; 21: 407-12.
13. Johnson DY, Luo Y, Jones KL, Chambers C,. Pregnancy outcomes in women exposed to adalimumab: an update on the Autoimmune Diseases in Pregnancy project [abstract]. Arthritis Rheum 2011; 63 Suppl: S730-31.
14. Kvien TK, Uhlig T, Odegard S, Heiberg MS,. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci 2006; 1069: 212-22.